VectorBuilder Plans $500 Million Gene Therapy Delivery CDMO in Guangzhou
publication date: Apr 14, 2022
VectorBuilder, a CDMO based in Chicago, announced plans to build a $500 million gene delivery manufacturing and research campus in Guangzhou. When finished, the site will include 30 production suites designed to manufacture lentivirus, plasmids, messenger RNA, adeno-associated virus, cell lines and other types of viral and non-viral vectors. VectorBuilder says it offers gene therapy delivery services so biopharmas can focus on their candidates instead of developing their own vectors. The new Guangzhou campus, which will take four years to complete, is part of a global expansion. More details....
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.